BridgeMD
New treatment option for Fatigue Symptom
Official title Adapting the FACETS Program to Sickle Cell Disease
ClinicalTrials.gov ID: NCT06650813
What this study is testing
- What it's testing
- Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant having freely given his oral agreement.
- Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
- Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions...
You likely can't join if
- Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study...
- Participants with another chronic pathology causing fatigue.
- Participants in vaso-occlusive crisis (VOC) or hospitalization.
- Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).
The study team makes the final eligibility decision.
Where it's taking place
- Grenoble, France
- Le Chesnay, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Grenoble, France; Le Chesnay, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.